Acadia Healthcare (ACHC)

• Market cap: $2.78B
• 1 day: -1.29%
• 5 days: 3.71%
• 1 month: 2.29%
• 3 months: -26.59%
• 6 months: -52.04%
• Year to date: -26.59%
• 1 year: -60.65%
• 5 years: 74.42%
• 10 years: -57.36%
• Sector: Healthcare
• Industry: Specialty Outpatient Facilities

About: Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.

Employees: 25,500

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

680% more call options, than puts

Call options by funds: $92.7M | Put options by funds: $11.9M

75% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 7 (+3) [Q4]

28% more repeat investments, than reductions

Existing positions increased: 113 | Existing positions reduced: 88

0% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 76

1.12% less ownership

Funds ownership: 109.17% [Q3] → 108.05% (-1.12%) [Q4]

1% less funds holding

Funds holding: 306 [Q3] → 302 (-4) [Q4]

38% less capital invested

Capital invested by funds: $6.42B [Q3] → $3.98B (-$2.44B) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $35 17% upside
• Avg. target: $48 62% upside
• High target: $66 121% upside

6 analyst ratings

• positive: 4 67%
• neutral: 2 33%
• negative: 0 0%

Mizuho Ann Hynes 67% 1-year accuracy 10 / 15 met price target	24% upside $37	Neutral Maintained	25 Mar 2025
RBC Capital Ben Hendrix 41% 1-year accuracy 27 / 66 met price target	44% upside $43	Outperform Maintained	3 Mar 2025
Keybanc Matthew Gillmor 36% 1-year accuracy 5 / 14 met price target	117% upside $65	Overweight Maintained	3 Mar 2025
Barclays Andrew Mok 41% 1-year accuracy 24 / 58 met price target	17% upside $35	Equal-Weight Downgraded	28 Feb 2025
B of A Securities Kevin Fischbeck 42% 1-year accuracy 10 / 24 met price target	49% upside $45	Buy Maintained	28 Feb 2025